ARKG Holdings of TEM
Tempus
Tempus is a biotechnology company that leverages artificial intelligence and data analytics to advance precision medicine, primarily in oncology and other therapeutic areas. It makes money by providing genomic sequencing, clinical data aggregation, and AI-driven insights to healthcare providers, researchers, and pharmaceutical companies to support tailored treatment plans, drug development, and clinical trials.
Trades of TEM in ARKG
The ten most recent trades of Tempus in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 17, 2025 | Buy | $955,360 | 2.03% | 0.09% |
| Jan 17, 2025 | Buy | $955,360 | 2.03% | 0.09% |
| Jan 17, 2025 | Buy | $955,360 | 2.03% | 0.09% |
| Jan 13, 2025 | Buy | $3,261,738 | 7.94% | 0.30% |
| Jan 03, 2025 | Buy | $1,958,365 | 4.49% | 0.17% |
| Dec 27, 2024 | Buy | $5,384,030 | 14.22% | 0.45% |
| Dec 18, 2024 | Buy | $1,692,921 | 4.60% | 0.15% |
| Dec 17, 2024 | Buy | $1,770,695 | 4.68% | 0.15% |
| Dec 13, 2024 | Buy | $568,301 | 1.43% | 0.05% |
| Dec 11, 2024 | Buy | $3,183,138 | 8.79% | 0.26% |